Screener
Denali Therapeutics Inc. DNLI Common stock, par value (in dollars per share)
Common stock, par value (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Denali Therapeutics Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.
The source filing: Denali Therapeutics Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:08 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0001714899-26-000097
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Commitments and contingencies (Note 10) | ||
| Stockholders' equity: | ||
| Convertible preferred stock, $0.01 par value; 40,000,000 shares authorized as of June 30, 2026 and December 31, 2025; 0 shares issued and outstanding as of June 30, 2026 and December 31, 2025 | — | — |
| Common stock, $0.01 par value; 400,000,000 shares authorized as of June 30, 2026 and December 31, 2025; 159,755,526 shares and 156,182,177 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | 1,924 | 1,888 |
| Additional paid-in capital | 3,142,747 | 3,062,715 |
| Accumulated other comprehensive income (loss) | (1,969) | 682 |
| Accumulated deficit | (2,307,524) | (2,051,524) |
| Total stockholders' equity | 835,178 | 1,013,761 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Denali Therapeutics Inc.'s common stock, par value (in dollars per share)?
- Denali Therapeutics Inc. (DNLI) reported common stock, par value (in dollars per share) of $0.01 in Q2 2026.
- How has Denali Therapeutics Inc.'s common stock, par value (in dollars per share) changed year-over-year?
- Denali Therapeutics Inc.'s common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0.01 to $0.01.
- What is the long-term trend for Denali Therapeutics Inc.'s common stock, par value (in dollars per share)?
- Over 5 years (2020 to 2025), Denali Therapeutics Inc.'s common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0.01 to $0.01.
- What does common stock, par value (in dollars per share) mean?
- Common stock, par value (in dollars per share)
Ask your AI about Denali Therapeutics Inc.'s common stock, par value (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude